MRVI in the 13F filings
Maravai Lifesciences HLDGS I · CUSIP 56600D107
- Quarter end
- 30 Jun 2024
- the date the book describes
- Filed
- 16 Sep 2024
- latest of these filings; the earliest 9 Aug 2024
- Managers listing it
- 6
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q1 2024 and Q2 2024; 3 listed it in both
- Shares listed
- 12,764,966
- combined, among listed positions
- Reported value
- $91m
- combined, at the quarter end
Among the 94 comparable managers: 4 buyers (opened or added shares) and 2 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing MRVI in Q2 2024
6 of 6 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Marshall Wace LLP | 4,004,884 | $29m | under 0.1% | Trimmed | -824,862 | 14 Aug 2024 (the filing on sec.gov) |
| Renaissance Technologies LLC | 3,881,441 | $28m | under 0.1% | Added | +668,552 | 9 Aug 2024 (the filing on sec.gov) |
| Point72 Asset Management LP | 3,519,561 | $25m | 0.07% | Added | n.a. | 16 Sep 2024 (the filing on sec.gov) |
| Dragoneer Investment Group LLC | 750,468 | $5.4m | 0.10% | New | new | 14 Aug 2024 (the filing on sec.gov) |
| Hudson Bay Capital Management LP | 472,793 | $3.4m | under 0.1% | Trimmed | -63 | 14 Aug 2024 (the filing on sec.gov) |
| PDT Partners LLC | 135,819 | $972k | 0.09% | New | new | 15 Aug 2024 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Dragoneer Investment Group LLCnew position · 750,468 shares now+750,468
- Renaissance Technologies LLCexisting position · 3,881,441 shares now+668,552
- PDT Partners LLCnew position · 135,819 shares now+135,819
Reductions
- Marshall Wace LLPexisting position · 4,004,884 shares now-824,862
- Hudson Bay Capital Management LPexisting position · 472,793 shares now-63
New positions and exits
New (2)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2020 | 11 | $410m | n.a. | n.a. |
| Q1 2021 | 4 | $230m | n.a. | n.a. |
| Q2 2021 | 8 | $819m | n.a. | n.a. |
| Q3 2021 | 10 | $1.4bn | n.a. | n.a. |
| Q4 2021 | 6 | $900m | n.a. | n.a. |
| Q1 2022 | 4 | $342m | n.a. | n.a. |
| Q2 2022 | 4 | $447m | n.a. | n.a. |
| Q3 2022 | 7 | $527m | n.a. | n.a. |
| Q4 2022 | 8 | $360m | n.a. | n.a. |
| Q1 2023 | 8 | $291m | n.a. | n.a. |
| Q2 2023 | 7 | $234m | n.a. | n.a. |
| Q3 2023 | 6 | $155m | n.a. | n.a. |
| Q4 2023 | 3 | $73m | 2 | 1 |
| Q1 2024 | 5 | $110m | 2 | 3 |
| Q2 2024 | 6 | $91m | 4 | 2 |
| Q3 2024 | 1 | $34m | 1 | 1 |
| Q4 2024 | 1 | $251k | n.a. | n.a. |
| Q3 2025 | 1 | $1.3m | 1 | 0 |
| Q4 2025 | 1 | $5.8m | 13 | 9 |
| Q1 2026 | 1 | $7.1m | 13 | 7 |
| Q2 2026 | 2 | $24m | 19 | 7 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
MRVI and LLY →MRVI and JNJ →MRVI and VRTX →Choose a stock to compare with MRVI →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own MRVI, latest filings →Back to the 13F Explorer →